News
OpenAI Cleared To Launch GPT-5.6 Publicly After Government Review
The Trump administration’s 30-day review lasted barely two weeks, and OpenAI says it doesn’t want the review process to become the default.
OpenAI will release all three GPT-5.6 variants — Sol, Terra, and Luna — to the public on Thursday, July 9, ending a staggered debut shaped by a new US government review process. “We’re expanding preview access globally now,” the company announced on X.
The model series launched in late June to a “small group of trusted partners,” a restriction stemming from President Trump’s AI cybersecurity order signed in early June, which asks companies to voluntarily submit their most powerful models for government review 30 days before public release. OpenAI complied, though not happily. “We don’t believe this kind of government access process should become the long-term default,” it said at the time, adding that cooperation was the fastest route to a public launch.
The review wrapped up well short of 30 days. According to Axios, the administration cleared the wider release after the Department of Commerce’s Center for AI Standards and Innovation ran additional tests, with OpenAI sending technical experts to Washington to field questions and concerns directly.
Also Read: WhatsApp Usernames Are Coming: Here’s How To Claim Yours
Of the three variants, Sol is the company’s strongest model to date, priced at $5 per million input tokens and $30 per million output. Terra, built for everyday use, promises performance comparable to GPT-5.5 at half the cost — $2.50 per million input and $15 for output — while Luna, the cheapest of the trio, runs $1 per million input and $6 for output.
OpenAI is not the only lab navigating the new regime. Anthropic was ordered to block foreign nationals from its Mythos and Fable models, and has since won permission to redeploy them.
News
A Three-Clinic Network Bets Dubai Is Ready For Longevity Medicine
Longevium has enlisted nearly 100 clinicians and created an AI platform in a bid to sell biological-age tracking as a medicine, not a wellness service.
Dubai has been busily creating the scaffolding for a longevity industry, including a dedicated regulatory authority and a health market deep enough to sustain it. Now the clinics are arriving.
Longevium, a longevity clinic network, has opened three locations across the city: a flagship at Triple Seven Mall on Jumeirah 3, and branches in Jumeirah Lake Towers and Jumeirah Village Circle. Together they house a multidisciplinary team of nearly 100 physicians and specialists offering what the company bills as “a measurable medical system for longevity”.

The pitch is that longevity medicine should look less like a wellness menu and more like continuous clinical care. Each patient’s biological age assessment, laboratory results, body composition, cardiovascular risk factors, metabolic markers, and lifestyle data feed into a single profile, with a proprietary AI platform helping physicians track progress and adjust protocols against the patient’s own biomarkers.
“Healthy aging must be approached clinically through diagnostics, biomarkers, physician supervision, longitudinal tracking, and protocols tailored to the individual,” said Dr. Ksenia Butova, Longevium’s founder and CEO. “Our goal is to help patients understand their health trajectory before disease develops, and then actively change that trajectory”.
The treatment list spans peptide-based protocols, exosome therapies, stem cell approaches, GLP-1 metabolic optimization, hormone balance programs, cardiovascular prevention, and regenerative aesthetics — a model built for the entrepreneurs, executives, and international patients the clinic says want measurable results rather than generic wellness. A signature offering, Longevity Day, compresses biomarker testing, ultrasound and vascular imaging, specialist consultations, IV therapy, and a personalized optimization roadmap into a single three-hour visit.
Also Read: Dubai Certifies The World’s First Purpose-Built Air Taxi Vertiport
“Here, longevity, biotechnology, AI, prevention, and regenerative medicine are converging into a single ecosystem,” said Butova. “This is why Longevium was built in Dubai, and why we believe the UAE can become a global reference point for longevity medicine”.
The emirate established the Dubai Longevity Authority in 2026 to oversee its longevity, wellness, and advanced health sectors, and the Dubai Health Authority reported insured beneficiaries exceeding 4.9 million in 2025, up around 6.5%, with insurance claims reaching approximately 49.6 million, up around 13.5%.
-
News2 months agoDJI Teases Dual-Camera Osmo Pocket 4P For 2026 Launch
-
Web32 months ago2026 Crypto Trends: Bitcoin, ETFs & The Future Of Payments
-
News2 months agoLebanon Ministers Meet Visa Over National Digital Payment Platform
-
News2 months agoAt I/O 2026, Sundar Pichai Concedes AI Must Deliver Real Value
